Thyroid transcription factor 1 (TTF‐1) negativity as a predictor of unfavorable response to EGFR‐TKI therapy in advanced lung adenocarcinoma patients with EGFR mutations

BACKGROUND: The absence of thyroid transcription factor 1 (TTF‐1) is associated with a lower frequency of epidermal growth factor receptor (EGFR) mutations in lung adenocarcinoma (LUAD). The aim of this study was to assess the impact of TTF‐1 expression on the clinical response to EGFR‐tyrosine kina...

Descripción completa

Detalles Bibliográficos
Autores principales: Ding, Xiaosheng, Shi, Weiwei, Han, Bingxuan, Chen, Hanxiao, Li, Jia, An, Juan, Zhou, Lili, Xu, Weiran, Shi, Hui, Zheng, Xixi, Hua, Yichun, Li, Xiaoyan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons Australia, Ltd 2023
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10569904/
https://www.ncbi.nlm.nih.gov/pubmed/37605791
http://dx.doi.org/10.1111/1759-7714.15079

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10569904/
https://www.ncbi.nlm.nih.gov/pubmed/37605791
http://dx.doi.org/10.1111/1759-7714.15079

Ejemplares similares